Connect with us

Technology

BOARDWALKTECH REPORTS SECOND QUARTER FISCAL 2025 FINANCIAL RESULTS

Published

on

CUPERTINO, Calif., Nov. 27, 2024 /CNW/ – (TSXV: BWLK) (OTCQB: BWLKF) – Boardwalktech Software Corp. (“Boardwalktech” or the “Company”), a leading digital ledger platform and enterprise software solutions company, is pleased to report its financial results for the three-month period ended September 30, 2024 (“Q2-FY25”).  All figures are reported in U.S. dollars, unless otherwise indicated. Boardwalktech’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).  Please refer to the Unaudited Condensed Consolidated Financial Statements and Management’s Discussion and Analysis (“MD&A”) for the three and six month period ended September 30, 2024, filed on SEDAR+ at www.sedarplus.ca for more information.

Financial Highlights:

Revenue for Q2-FY25 was $1.28 million, a 2% increase from $1.25 million in Q1-FY24, but a 16% decline from $1.53 million in Q2-FY24.Annual recurring revenue (“ARR”), at September 30, 2024 was $4.6 million is a non-IFRS measure, and the Company defines ARR as the recurring revenue expected based on annual license subscriptions and recurring services.Gross margin for Q2-FY25 was 88.6%, up slightly from Q1-FY25 level of 87.9% due to lower costs, but down slightly from 90.1% in Q2-FY24 due to lower revenue levels year-over-year.Adjusted EBITDA for Q2-FY25 was a loss of $(0.37) million, a 10% improvement versus the $(0.41) million loss in Q1-FY25, and a 2% change versus $(0.36) million in Q2-FY24, as adjusted operating expenses of $0.6 million are lower year-to date versus the comparable period last year. As a result, despite lower revenue levels than last year, cash from operations was a positive $0.2 million in the recent quarter.Non-IFRS net loss for Q2-FY25 (as defined in the Non-IFRS Financial Measures section) totaled $(0.5) million, or a loss of $(0.01) per basic and diluted share, versus a $(0.5) million non-IFRS loss in Q1-FY25, or a loss of $(0.01) per basic and diluted share, and versus a $(0.4) million non-IFRS loss in Q2-FY24, or a loss of $(0.01) per basic and diluted share.Net loss for Q2-FY25 was $(0.7) million, or a loss of $(0.01) per basic and diluted share, a 10% improvement versus a $(0.8) million loss in Q1-FY25, or $(0.02) per basic and diluted share, and a 1% improvement versus $(0.7) million loss in Q2-FY24, or $(0.02) per basic and diluted share, despite the lower revenue levels.As of September 30, 2024, Boardwalk had $0.2 million of cash plus $0.6 million of collectible receivables, $2.2 million of debt, and $0.1 million of working capital (excluding deferred revenue). As of the most recent month certification, the Company has $0.9 million of a credit facility available.

“We continue to execute on our updated strategy and positioning established at the beginning of this year,” said Andrew T. Duncan, Chief Executive Officer of Boardwalktech. “In the banking sector, the Velocity product continues to grow within our largest customer, a top 5 US bank. We now have over 70 trained and dedicated people from three different partners working on this deployment, which is now in use by over 1,000 professionals within the bank. Velocity is producing the expected ROI and compliance required and this customer is now accelerating the deployment which will be a multi-year engagement. We continue to sign contracts with new partners as we expand our channel sales strategy. We are in multiple later stage deals with several partners and are enthusiastic about the pipeline of opportunities through the partner channel. We continue to see growth and expansion from existing customers and will see both new direct sales and channel sales contracts based on interest in the Boardwalk’s software solutions. The foundation has now been set for growth in 2025, including an anticipated increase in revenue and an overall improvement in the business.”

Earnings Conference Call Details

Boardwalktech management will be hosting its earnings conference call today (Novembert 27, 2024)
          Time:  at 4:30 PM Eastern Time / 1:30 PM Pacific Time.

To join the call, please use the following dial-in information:

US/Canada:                        1-888-510-2154 (toll free) or 437-900-0527 (Local – Toronto)
Audience URL:                  https://app.webinar.net/A2zRLJKnBDe   (copy & paste to your browser)

Replay: A replay of the call will be available until December 4, 2024 and can be accessed by dialing 1-888-660-6345 and entering access code 57639#

About Boardwalktech Software Corp.

Boardwalktech has developed a patented Digital Ledger Technology Platform currently used by Fortune 500 companies running mission-critical applications worldwide. Boardwalktech’s digital ledger technology and its unique method of managing vast amounts of structured and unstructured data is the only platform on the market today where multiple parties can effectively work on the same data simultaneously while preserving the fidelity and provenance of the data. Boardwalktech can deliver collaborative, purpose-built enterprise information management applications on any device or user interface with full integration with enterprise systems of record in a fraction of the time it takes other non-digital ledger technology-based platforms. Boardwalktech is headquartered in Cupertino, California with offices in India and operations in North America. For more information on Boardwalktech, visit our website at www.boardwalktech.com.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance, or achievements of the Company to be materially different from those expressed or implied by such information and statements.

An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading “Risk Factors” in the Company’s filing statement dated May 30, 2018. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/boardwalktech-reports-second-quarter-fiscal-2025-financial-results-302317774.html

SOURCE Boardwalktech Software Corp.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Tampax spotlights all-star athlete lineup led by Olivia Miles, bringing “Queen’s Court” fan experience to women’s basketball’s biggest moments

Published

on

By

CINCINNATI, April 20, 2026 /PRNewswire/ — Rising star Olivia Miles is leading Tampax’s growing roster of elite athletes, as the brand spotlights its commitment to supporting women in sport through confidence, performance and trusted protection.

Experience the full interactive Multichannel News Release here: https://www.multivu.com/tampax/9386052-en-tampax-and-all-star-lineup-brings-queens-court-fan-experience-to-wnba

All-star lineup empowering, educating women in sports

In partnership with WNBA draftee Olivia Miles and Olympic medalist Maia Shibutani, Tampax is continuing its commitment to support women in sport — bridging winter and summer athletes through a shared focus on performance and preparation.

“As an athlete, every detail matters when it comes to performance, and that includes how I manage my period,” said Miles. “Partnering with Tampax feels incredibly empowering because they truly understand the need for reliable protection that allows us to compete at the highest level without a second thought. But it’s more than just reliable protection; it’s about trusting the products you use on and off the court.”

“As an Olympic athlete, I know firsthand that periods don’t take a break for training or competition. The need for reliable, comfortable, and safe period care is universal across all sports – whether you’re on the ice, court, or anywhere else,” shared Shibutani. “Seeing organizations like Tampax step up to champion female athletes, and to provide products that instill confidence and trust, is vital for breaking down stigmas and empowering the next generation.”

As part of its associate partnership with the 2026 WNBA Draft presented by State Street Investment Management SPY, Tampax introduced “Queen’s Court,” an interactive, fan-facing experience designed to connect fans to the energy and culture of the game—bringing them closer to the athletes and moments shaping women’s basketball.

Tampax provided athletes and fans alike the opportunity to explore its unique space prior to the draft, which included access to #1 US OB/GYN recommended tampons *based on a 2026 survey designed for comfort and performance.

“Our partnership with the WNBA, and specifically our presence at the WNBA Draft with the Queen’s Court, is a natural and powerful alignment for Tampax,” said Chelsey Harshman, Senior Brand Director at Tampax.

“We understand the unique challenges women athletes face, and our mission is to ensure that period care is never a point of concern or limitation. By being the Official Period Protection Partner of the WNBA and the Toronto Tempo, we’re not just providing products; we’re providing confidence, comfort, and the assurance of trusted protection built on safe ingredients.”

Why is Tampax partnering with women’s professional sports?
Because performance doesn’t pause for a period.

Tampax is helping normalize conversations around periods and empowering women to be at their best while ensuring athletes have access to protection they can trust.

Through its women sports partnerships, Tampax is:

Providing reliable and safe period protection designed for athlete comfort and performanceHelping break stigma around periods in sportsReinforcing the importance of knowing and trusting the products athletes use

The goal is simple: give athletes one less thing to think about, so they can focus on their game.

About Olivia Miles
Olivia Miles is a rising star and one of the faces of the next generation of the WNBA. A native of Phillipsburg, New Jersey, she starred at Notre Dame before finishing her collegiate career at TCU. During her collegiate career, Miles earned All-American honors and multiple All-Conference selections, while consistently ranking among the national leaders in assists. She was selected as the No. 2 overall pick in the 2026 WNBA Draft, cementing her status as a rising star at the professional level.

About Maia Shibutani
Maia Shibutani is a two-time Olympic medalist, author, producer, and speaker. Alongside her brother and ice dance partner Alex Shibutani, she made history as part of the first ice dance team of Asian descent, and the first team of color, to medal at the Olympic Winter Games. The duo are three-time World medalists, five-time U.S. National Champions, and were inducted into the U.S. Figure Skating Hall of Fame in 2023.

Off the ice, Maia is a co-author of the “Kudo Kids” series and the children’s books Amazing: Asian Americans and Pacific Islanders Who Inspire Us All (2023) and Incredible: Asian Americans and Pacific Islanders Who Changed the World (2025), and is developing film and television projects. She is an advocate for education, diversity, and representation, serving in ambassador roles with organizations including the U.S. Department of State and Right To Play. Her honors include the Asia Society Game Changer Award, induction into the Asian Hall of Fame, and recognition as a Gold House A100 honoree.

About Tampax
Procter & Gamble‘s leading tampon brand, Tampax, exists to help women and girls better manage their periods through superior internal period protection and medically accurate period education. With more than 80 years of period protection expertise, Tampax meets a variety of needs with a product lineup that includes Tampax Pearl, Tampax Radiant, Tampax Pure Cotton, and Tampax Pocket Radiant. Only Tampax tampons offer a LeakGuard™ Braid and five absorbency sizes to help provide leak-free periods.

About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

Contact

Amanda Brown
Senior Communications Manager, North America Feminine Care
brown.a.8@pg.com

 

 

View original content:https://www.prnewswire.com/news-releases/tampax-spotlights-all-star-athlete-lineup-led-by-olivia-miles-bringing-queens-court-fan-experience-to-womens-basketballs-biggest-moments-302746382.html

SOURCE Tampax

Continue Reading

Technology

Oracle Health Demonstrates Interoperability Leadership, Achieves CMS Aligned Network Status

Published

on

By

Delivers solution to eliminate check-in paperwork by leveraging CLEAR1 in support of CMS’ “Kill the Clipboard” initiative

AUSTIN, Texas, April 20, 2026 /PRNewswire/ — Advancing its mission to provide patients with access to their healthcare data when and where they need it, Oracle Health is now a Centers for Medicare & Medicaid Services (CMS) Aligned Network. Oracle Health has also developed and delivered an easy-to-implement solution that allows patients to digitally verify their identity and provide access to their health records at check-in. This eliminates redundant information gathering and reflects Oracle Health’s commitment to reducing the administrative burden across the healthcare ecosystem and increasing interoperability.

“Oracle Health is committed to making sure patients have access to and remain in control of their health data. Our participation in the CMS Aligned Networks will help health systems and patients connect data across settings, reduce fragmentation, and improve how clinicians and patients access the information they need,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “Oracle will continue working with government and industry leaders to deliver a secure, interoperable, and AI-enabled healthcare system that improves experiences for patients and clinicians while driving down the cost of care delivery.”

Streamlining the patient intake process

CMS’ “Kill the Clipboard” initiative encourages providers to replace paperwork intake processes with a seamless digital check in. Oracle will be integrating CLEAR1, CLEAR’s secure identity platform, to enable patients with a simple way to check in and give providers access to the health data they have opted to share by simply showing a QR code. The data will then flow directly into EHR workflows. CLEAR1 is Full Service certified by the Kantara Initiative for NIST Identity Assurance Level 2 (IAL2) and Authenticator Assurance Level 2 (AAL2), high-assurance standards that are foundational to trusted healthcare data exchange.

“Healthcare has long relied on fragmented, manual intake processes that create friction for patients and administrative burden for providers,” said David Bardan, SVP, Head of Healthcare, CLEAR. “By integrating CLEAR1 with Oracle Health, we’re working to help eliminate the clipboard entirely—enabling a simple, secure digital check-in that verifies the person and seamlessly connects their information into clinical workflows. This will be a meaningful step toward a more interoperable, patient-centered healthcare experience where trust, privacy, and ease of use are built into every interaction.”

New Jersey-based health system AtlantiCare is already using the solution to drive a better, more connected care experience for patients and providers.

“As one of the first healthcare systems in the nation to pledge support for the CMS Interoperability Framework, AtlantiCare is excited to partner with Oracle Health to deliver on that vision,” said Jordan Ruch, CIO of AtlantiCare. “We’ve completed full integration of this technology into our ambulatory check-in workflows, positioning us to deliver a faster, paper-free experience for patients, providers, and staff. This eliminates waiting room forms and repetitive medical history collection, with verified patient information flowing securely and seamlessly into our system as we prepare for broader rollout.”

Simplifying patient and provider access to health information

In addition to unveiling its offering to eliminate paperwork at check in, Oracle Health has taken another step toward helping accelerate secure, patient-centered healthcare data sharing by becoming a CMS Aligned Network. This most recent achievement builds on years of work enabling standards-based data exchange across care settings.

By becoming a CMS Aligned Network, Oracle Health has demonstrated its technology supports CMS-aligned approaches to simplify and accelerate healthcare data sharing for patients and providers. Oracle Health’s open and interoperable platform communicates with other CMS Aligned Networks as well as Qualified Health Information Networks® (QHINs) to create a single front door for patients to access and share their health information with providers.

Oracle Health is committed to enabling patient access to health data that is as simple as accessing bank records and is available conveniently when and where they need it. Last year, Oracle Health Information Network Inc., a subsidiary of Oracle, became a designated QHIN as a part of the Trusted Exchange Framework and Common Agreement™ (TEFCA™).

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-health-demonstrates-interoperability-leadership-achieves-cms-aligned-network-status-302746757.html

SOURCE Oracle

Continue Reading

Technology

OrthAlign Accelerates Global Growth Strategy with Announcement of CE Mark in Europe

Published

on

By

IRVINE, Calif., April 20, 2026 /PRNewswire/ — OrthAlign, Inc., the leader in handheld orthopedic enabling technology, today announced it has received CE Mark under the EU MDR for its portfolio of navigation solutions, enabling commercialization across European markets. Both the Lantern® and OrthAlign Plus® platforms are now CE marked and available for sale.

This milestone expands access to OrthAlign’s proven technology across a region increasingly focused on efficiency, flexibility, and cost control in joint replacement.

OrthAlign’s handheld systems are well aligned with the needs of European healthcare systems. Delivered in a single-use format with per-case pricing, the technology eliminates the need for capital equipment, service contracts, and complex infrastructure. Hospitals and ambulatory surgical centers can more easily manage costs while maintaining access to advanced surgical technology.

“Our technology was designed to be accessible and easy to implement,” said Eric Timko, CEO of OrthAlign. “With no pre-operative imaging requirements, minimal training, and rapid product availability, we enable surgeons to adopt technology without disrupting existing workflows.”

OrthAlign’s open-platform supports compatibility with all major implant systems, giving surgeons flexibility across techniques and preferences while helping facilities standardize solutions across sites of care. It delivers consistent outcomes across total knee, revision knee, partial knee and total hip procedures.

With more than 450,000 procedures performed globally, OrthAlign has established a strong track record of delivering accurate, real-time data while maintaining procedural efficiency. The systems are designed to integrate seamlessly into the operating room, offering time-neutral performance compared to manual techniques without the added complexity of traditional navigation or robotics.

“The European market is increasingly prioritizing solutions that balance clinical performance with operational and economic efficiency,” added Timko. “We believe OrthAlign is uniquely positioned to meet that need.”

OrthAlign will begin immediate commercial rollout in key European markets, supported by distribution partners and clinical education programs. For distribution inquiries please contact info@orthalign.com

About OrthAlign

OrthAlign, Inc. is a global medical device company focused on delivering simple, accurate, and cost-effective handheld technology for joint replacement surgery. Its product portfolio, including OrthAlign Plus and Lantern, empowers surgeons with real-time data to improve alignment and procedural efficiency, without the need for capital equipment.

View original content to download multimedia:https://www.prnewswire.com/news-releases/orthalign-accelerates-global-growth-strategy-with-announcement-of-ce-mark-in-europe-302747234.html

SOURCE OrthAlign

Continue Reading

Trending